Abacavir Sulfate, Dolutegravir Sodium, Lamivudine
Triumeq, Triumeq PD
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
$130.0048
No Shortage
Tier 1: 35.9%
Abacavir Sulfate, Dolutegravir Sodium, Lamivudine suppresses hepatitis B virus replication.
vs. brand Triumeq: Generic saves up to -1200% per unit
Generic Manufacturers
VIIV HEALTHCARE CO
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.